Olema Pharmaceuticals, Inc. (OLMA)
6.58
-0.29
(-4.22%)
USD |
NASDAQ |
Oct 16, 16:00
6.58
0.00 (0.00%)
After-Hours: 20:00
Olema Pharmaceuticals Net Income (TTM) : -204.57M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -204.57M |
| March 31, 2026 | -185.15M |
| December 31, 2025 | -162.45M |
| September 30, 2025 | -149.96M |
| June 30, 2025 | -142.30M |
| March 31, 2025 | -128.89M |
| December 31, 2024 | -129.47M |
| September 30, 2024 | -122.68M |
| June 30, 2024 | -109.63M |
| March 31, 2024 | -99.34M |
| December 31, 2023 | -96.66M |
| September 30, 2023 | -96.06M |
| Date | Value |
|---|---|
| June 30, 2023 | -97.28M |
| March 31, 2023 | -110.04M |
| December 31, 2022 | -104.79M |
| September 30, 2022 | -100.25M |
| June 30, 2022 | -95.24M |
| March 31, 2022 | -78.79M |
| December 31, 2021 | -71.10M |
| September 30, 2021 | -59.59M |
| June 30, 2021 | -49.72M |
| March 31, 2021 | -35.77M |
| December 31, 2020 | -22.12M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| SELLAS Life Sciences Group, Inc. | -32.46M |
| Puma Biotechnology, Inc. | 26.72M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| Anika Therapeutics, Inc. | -3.121M |